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What Is Professionalism?
I n reading the Special Article in the August 8/22,2011, issue of the Archives, with the subtitle “Meet-ing the Responsibility of Professionalism” it ap-
peared to me that this was a subject of quality perfor-
mance.1 As defined in the dictionary, professionalism is
the conduct, aims, or qualities that characterize or mark
a profession or a professional person. General rules of
behavior apply to all professions. Inmedicine these quali-
ties are particularly compelling becausemuch of our fees
involve outside organizations including the federal gov-
ernment. A relevant article was recently published ad-
dressing this subject as well as health care reform, of vi-
tal interest to both our profession and the public.2 This
bill has now been passed but is subject to court chal-
lenges. Inmy view, professionalism for a physicianmeans
placing the interests of the patient ahead of his or her
own interests, including financial interests. Many indi-
vidual physicians support this bill, but in my opinion
medical professional organizations are not enthusiastic
about or in support of cost-cuttingmeasures thatwill affect
their income.
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In reply
Dr Finestone inquires whether the generation of the “Top
5” lists by the Good Stewardship working groups is better
characterized as a subject of quality performance rather than
professionalism. Our characterization of the effort as pro-
fessionalism arises from the Physician Charter, in which the
definition of professionalism rests, in part, on the principle
of social justice. The charter ethically commits physicians
to work toward “the wise and cost-effective management of
limited clinical resources.”1
The ethical principle of justice requires that everyone be
treated fairly. Professionalism requires that resources be
used wisely. Both assure that resources are allocated in the
fairest and most effective manner. Making wise clinical
decisions and being good stewards of clinical resources cre-
ates a health system that provides the best care to the most
people.
The “Top 5” lists are not merely clinical guidelines but a
fundamental appeal to physicians’ sense of professional ob-
ligation to achieve a sustainable health care system for all
Americans. This epitomizes the concept of professionalism.
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Do Procalcitonin Algorithms
Modify Mortality?
I n reporting the results of the systematic review “Pro-calcitonin Algorithms for Antibiotic Therapy De-cisions: A Systematic Review of Randomized Con-
trolled Trials and Recommendations for Clinical
Algorithms,” Schuetz et al1 state thatmeasurement of pro-
calcitonin (PCT) levels for antibiotic decisions in pa-
tients with respiratory tract infections and sepsis does not
worsen the mortality rate. We are doubtful about their
conclusions.We believe that the meta-analysis is under-
powered to provide evidence that PCT can affect mor-
tality. Mortality was the primary outcome in only 3 of
14 randomized controlled trials included in the study,
and in the primary setting studies (approximately 25%
of the subjects) death was an extremely rare event (1
event). A second issue to be addressed is that the meta-
analysis involved trials with very different clinical set-
tings (clinical heterogeneity); thus, wewonder if it should
be more appropriate to perform a random effect analy-
sis, irrespectively of the statistical significance of the
heterogeneity. Finally, regarding themethodological qual-
ity of original randomized controlled trials, we ask the
authors if the global adherence to the protocols (that was
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low in almost all studies) can be a bias affecting the re-
sults of the meta-analysis.
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In reply
The aims of our review were to summarize results of pre-
vious randomized controlled trials investigating the effects
of procalcitonin protocols for antibiotic stewardship deci-
sions, with particular focus on the different protocols used,
and to propose clinical algorithms for use in future trials.
We found that none of the trials reported increased rates of
mortality or other adverse outcomes; yet, only 4 of themwere
noninferiority trials and adequately powered to addressmor-
taility.1-4 Mortality was also similar between groups in a
pooled analysis using aggregate data of individual trials, but
we agreewith Ferrari et al that these results should be viewed
with caution.
The 95% confidence interval cannot rule out a clinically
relevant increase inmortality in high-risk settings, and other
relevant clinical outcomes were not considered for pooled
analysis. Although a sensitivity analysis using a random ef-
fects model (summary odds ratio for mortality, 0.91; 95%
CI, 0.73-1.15) confirms our previous results with the Peto
method, the differences in settings, patient acuity, underly-
ing type of infection, and methodological quality of trials
make an aggregate data meta-analysis a suboptimal choice.
Therefore, an individual patient data meta-analysis focus-
ing on patients with acute respiratory tract infections with
a comprehensive list of patient-relevant outcomes, stan-
dardized outcome definitions across trials, and predefined
sensitivity and subgroup analyses is under way in an at-
tempt to resolve these remaining uncertainties.5 Within this
analysis we also aim to investigate whether methodologi-
cal shortcomings, such as the low adherence rates in some
of the studies, would influence the interpretation of results.
We also agree that future work is needed to confirm the
safety of procalcitonin protocols, particularly in non-
European countries and in critical care settings. Toward this
aim,we believe that our reviewprovides important and timely
information and that the proposed algorithms are a sum-
mary of the current state of knowledge in the field. We hope
that this may lay ground for future research to tackle the
existing vicious cycle of antibiotic overuse and emerging bac-
terial resistance.
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